Literature DB >> 7780643

Copper chelation-induced reduction of the biological activity of S-nitrosothiols.

M P Gordge1, D J Meyer, J Hothersall, G H Neild, N N Payne, A Noronha-Dutra.   

Abstract

1. The effect of copper on the activity of the S-nitrosothiol compounds S-nitrosocysteine (cysNO) and S-nitrosoglutathione (GSNO) was investigated, using the specific copper chelator bathocuproine sulphonate (BCS), and human washed platelets as target cells. 2. Chelation of trace copper with BCS (10 microM) in washed platelet suspensions reduced the inhibition of thrombin-induced platelet aggregation by GSNO; however, BCS had no significant effect on the anti-aggregatory action of cysNO. BCS inhibited cyclic GMP generation in response to both cysNO and GSNO. 3. The effect of BCS was rapid (within 30 s), and could be abolished by increasing the platelet concentration to 500 x 10(9) l-1. 4. In BCS-treated platelet suspensions, the addition of Cu2+ ions (0.37-2.37 microM) led to a restoration of both guanylate cyclase activation and platelet aggregation inhibition by GSNO. 5. The anti-aggregatory activity of GSNO was reduced in a concentration-dependent manner by the copper (I)-specific chelators BCS and neocuproine, and to a smaller extent by desferal. No effect was observed with the copper (II) specific chelator, cuprizone, the iron-specific chelator, bathophenanthroline sulphonate, or the broader-specificity copper chelator, D-penicillamine. 6. In both BCS-treated and -untreated platelet suspensions, cys NO was more potent than GSNO as a stimulator of guanylate cyclase. In BCS-treated platelet suspensions there was no significant difference between the anti-aggregatory potency of cysNO and GSNO; however, in untreated suspensions, GSNO was significantly more potent than cysNO. Thus, when copper was available, GSNO produced a greater inhibition of aggregation than cysNO, despite being a less potent activator of guanylate cyclase. 7. The breakdown of cysNO and GSNO was measured spectrophotometrically by decrease in absorbance at 334 nm. In Tyrode buffer, cysNO (10 microM) broke down at a rate of 3.3 microM min-1. BCS (10 microM)reduced this to 0.5 microM min-1. GSNO, however, was stable, showing no fall in absorbance over a period of 7 min even in the absence of BCS.8. We conclude that copper is required for the activity of both cysNO and GSNO, although its influence on anti-aggregatory activity is only evident with GSNO. The stimulatory effect of copper is unlikely to be explained solely by catalysis of S-nitrosothiol breakdown. The enhancement by copper of the anti-aggregatory activity of GSNO, relative to cysNO, suggests that copper may be required for biological activity of GSNO which is independent of guanylate cyclase stimulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780643      PMCID: PMC1510308          DOI: 10.1111/j.1476-5381.1995.tb13317.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  ON THE NATURE OF COPPER IN ASCORBATE OXIDASE. I. THE VALENCE STATE OF COPPER IN THE DENATURED AND NATIVE ENZYME.

Authors:  W N POILLON; C R DAWSON
Journal:  Biochim Biophys Acta       Date:  1963-09-03

2.  Copper deficiency alters vasodilation in the rat cremaster muscle microcirculation.

Authors:  D A Schuschke; M W Reed; J T Saari; F N Miller
Journal:  J Nutr       Date:  1992-07       Impact factor: 4.798

3.  Understanding the controversy over the identity of EDRF.

Authors:  M Feelisch; M te Poel; R Zamora; A Deussen; S Moncada
Journal:  Nature       Date:  1994-03-03       Impact factor: 49.962

4.  S-nitroso-glutathione inhibits platelet activation in vitro and in vivo.

Authors:  M W Radomski; D D Rees; A Dutra; S Moncada
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 5.  Biochemistry of nitric oxide and its redox-activated forms.

Authors:  J S Stamler; D J Singel; J Loscalzo
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

6.  Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor.

Authors:  D I Simon; J S Stamler; O Jaraki; J F Keaney; J A Osborne; S A Francis; D J Singel; J Loscalzo
Journal:  Arterioscler Thromb       Date:  1993-06

7.  Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.

Authors:  J S Stamler; O Jaraki; J Osborne; D I Simon; J Keaney; J Vita; D Singel; C R Valeri; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways.

Authors:  B Gaston; J Reilly; J M Drazen; J Fackler; P Ramdev; D Arnelle; M E Mullins; D J Sugarbaker; C Chee; D J Singel; Joseph Loscalzo; Jonathan Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

9.  Glyceraldehyde-3-phosphate dehydrogenase is required for the transport of nitric oxide in platelets.

Authors:  B McDonald; B Reep; E G Lapetina; L Molina y Vedia
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  Biological activity of S-nitrosothiols: the role of nitric oxide.

Authors:  W R Mathews; S W Kerr
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

View more
  15 in total

1.  Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.

Authors:  T C Bellamy; J Wood; D A Goodwin; J Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Protein disulfide-isomerase mediates delivery of nitric oxide redox derivatives into platelets.

Authors:  Susannah E Bell; Chirag M Shah; Michael P Gordge
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

Review 4.  Application of metal coordination chemistry to explore and manipulate cell biology.

Authors:  Kathryn L Haas; Katherine J Franz
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

5.  Pre- and postjunctional protective effect of neocuproine on the nitrergic neurotransmitter in the mouse gastric fundus.

Authors:  J G De Man ; T G Moreels; B Y De Winter ; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Effect of Cu2+ on relaxations to the nitrergic neurotransmitter, NO and S-nitrosothiols in the rat gastric fundus.

Authors:  J G De Man; B Y De Winter; G E Boeckxstaens; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

7.  Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione.

Authors:  M P Gordge; J S Hothersall; G H Neild; A A Dutra
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

8.  S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase.

Authors:  N Hogg; R J Singh; E Konorev; J Joseph; B Kalyanaraman
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

Review 9.  S-nitrosothiols as selective antithrombotic agents - possible mechanisms.

Authors:  M P Gordge; F Xiao
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

10.  A photosensitive vascular smooth muscle store of nitric oxide in mouse aorta: no dependence on expression of endothelial nitric oxide synthase.

Authors:  Karen L Andrews; John J McGuire; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.